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Objective: To evaluate the antimalarial and antioxidant properties of stem bark extracts
of Haematostaphis barteri (H. barteri).
Methods: The prophylactic activity of the plant was performed by dosing mice with
sulfadoxine-pyrimethamine (1.2 mg/kg), aqueous extract (30, 100, 300 mg/kg) and
dichloromethane/methanol (D/M) (30, 100, 300 mg/kg) extracts ofH. barteri for 3 days. On
the 4th day, the mice were inoculated with Plasmodium berghei. The parasite density was
estimated for each mouse 72 h post-parasite inoculation. The curative activity of the plant
was also performed by inoculating mice with Plasmodium berghei. Three days later, they
were treatedwith artemether-lumefantrine (4mg/kg), aqueous andD/Mextracts ofH. barteri
stem bark for 5 days. The in vitro antioxidant property of the aqueous extract was determined
by using the reducing power, nitric oxide and total antioxidant capacity assays.
Results: The aqueous extract exerted signiﬁcant (P < 0.05) curative and prophylactic
antimalarial activities. The D/M extract exhibited signiﬁcant curative (P < 0.05) but not
prophylactic antiplasmodial effect. The aqueous extract exhibited in vitro antioxidant
property with IC50's of (0.930 ± 0.021) mg/mL, (0.800 ± 0.001) mg/mL and (0.22 ± 0.05)
mg/mL in the total antioxidant capacity, reducing power and nitric oxide assays. Histo-
logical assessment of the liver of aqueous and D/M treated animals did not reveal any
sign of toxicity.
Conclusions: H. barteri is not toxic which exerted signiﬁcant curative antiplasmodial
effects but the prophylactic property was however fraction dependent. The mechanism of
the antiplasmodial activity of H. barteri may partly be mediated by its antioxidant
property.1. Introduction
Malaria is still regarded as a major global infectious disease
in the 21st century, with a high pediatric mortality toll in the
developing world [1]. In Africa, malaria is one of the diseases
causing the most morbidity and mortality. The number of
Africans who die as a result of malaria each year is estimated
at 800 000 people of which a greater proportion is children
aged below 5 years [2]. This is coupled with the emergence
and spread of parasite resistance to well-established antima-
larial drugs and mosquito vectors resistant to insecticides. It is
therefore evident that newer agents with improved efﬁcacy andtoxicity should be developed. Medicinal plants presently
constitute a popular source of potential antimalarial agents.
About 30% of drugs for the management of diseases are ob-
tained from nature [2]. In this regard, Haematostaphis barteri
(H. barteri), commonly known as ‘‘blood plum’’, from the
Anacardiaceae family was studied for its antimalarial activity.
H. barteri is found in the northern region of Ghana. Different
ethnic groups use it for a number of reasons. Notable among
its uses include the leaves and bark infusion employed in the
treatment of malaria, hepatitis and sleeping sickness [3].
2. Materials and methods
2.1. Collection and identiﬁcation of plant material
The stem bark of H. barteri was collected from Wechiua in
the northern region of Ghana in the months of November toopen access article under the CC BY-NC-ND
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nist at the University of Cape Coast Herbarium and a voucher
specimen was deposited at the herbarium.
2.2. Preparation of plant extract
Preparation of the aqueous stem bark of H. barteri was done
by washing thoroughly the stem bark with tap water and sun-
dried. The dried stem bark was pulverized into ﬁne powder and
30.98 g of the powder was weighed and soaked in boiled water
for 3 days. The mixture was ﬁltered and freeze dried. To obtain
the dichloromethane/methanol (D/M) fraction, the plant sample
was extracted with D/M (1:1) solvent mixture. The extract was
concentrated under reduced pressure and dried on a water bath.
The dried material was then weighed, dissolved in water and
used for this study.
2.3. Screening for secondary metabolites
The aqueous and D/M extracts were screened for the pres-
ence of phytochemicals using standard procedures described
elsewhere [4–6].
2.4. Animals and husbandry
Institute for Cancer Research mice bred in the Animal
House of the School of Biological Sciences, University of
Cape Coast weighing between 20 and 30 g were used for the
antimalarial studies. The animals were housed in stainless steel
cages (34 cm × 47 cm × 18 cm) with soft wood shavings as
bedding, fed with normal commercial pellet diet (Agricare Ltd,
Kumasi, Ghana), given water ad libitum and maintained under
ambient laboratory conditions. All procedures and techniques
used in these studies were in accordance with the National
Institute of Health Guidelines for the Care and Use of Labo-
ratory Animals (Department of Health and Human Services
publication no. 85-23, 1985, revised 1996). All ethical pro-
tocols used for the study were approved by the Departmental
Ethics Committee.
2.5. Drugs and chemicals
Artemether-lumefantrine (A-L) used for the curative anti-
malarial test was obtained from Ajanta Pharma Ltd. (Mumbai,
India). Sulfadoxine/pyrimethamine (SP) was also obtained
from Maxheal Laboratories Pvt Ltd. (Sachin, India). Ascorbic
acid, ammonium molybdate, disodium hydrogen phosphate,
sodium dihydrogen phosphate, ferric chloride, potassium
ferricyanide, sodium bicarbonate, sodium carbonate and sul-
phuric acid were obtained from British Drug Houses, Poole,
England.
2.6. Curative antiplasmodial effect of stem bark extracts
of H. barteri
Mice were divided into eight groups and each inoculated with
1 × 106 Plasmodium berghei (P. berghei). About 72 h later,
parasitaemia was determined in all the mice followed by the
administration of the extracts. The various groups of mice were
treated with aqueous (30, 100 and 300 mg/kg; p.o.) and D/M(30, 100 and 300 mg/kg; p.o.) and A-L (1.14:6.9 mg/kg, p.o. for
5 days. The negative control group was treated with normal
saline. On Day 12, two animals from each group were randomly
selected and sacriﬁced. Their livers were harvested, ﬁxed in 4%
phosphate-buffered paraformaldehyde, and embedded in
parafﬁn. Sections were stained with hematoxylin and eosin, and
ﬁxed on glass slides for microscopic examination to estimate
parasite density [7].
2.7. Prophylactic effect of stem bark extracts of H.
barteri on P. berghei infection
The prophylactic antimalarial properties of the extracts were
determined by treating mice with aqueous (30, 100 and 300 mg/
kg), D/M (30, 100 and 300 mg/kg), SP (1.2 mg/kg) and normal
saline. The mice were treated daily for three consecutive days.
On Day 4, all the mice were infected with 1 × 106 P. berghei.
About 72 h later, blood smears were prepared from the tail of the
mice for the determination of parasite density [7].
2.8. In vitro antioxidant assays
2.8.1. Total antioxidant capacity
The antioxidant capacity or power of the aqueous extract was
evaluated by the phosphomolybdenum reduction method with
slight modiﬁcations [8]. The reagent solution prepared contained
ammonium molybdate (4 mmol/L), sodium phosphate
(28 mmol/L) and sulfuric acid (0.06 mol/L) mixed in 1:1:1
ratio respectively. Accurately 0.3 mL of the various
concentrations of the ascorbic acid (20–200 mg/mL) and
aqueous (20–200 mg/mL) were mixed with 3 mL of the reagent
solution. The mixture was incubated for 90 min at 95 C after
which the absorbance of the green phosphomolybdenum
complex formed was measured at 695 nm against a reagent
blank (0.3 mL distilled water and 0.3 mL reagent solution).
The results were expressed as ascorbic acid equivalents.
2.8.2. Reducing power capacity
The reducing power of aqueous was carried out using the
potassium ferricyanide method by mixing 1 mL of aqueous and
n-propyl gallate (20–200 mg/mL) with 2.5 mL phosphate buffer
(0.2 mol/L, pH 6.6) and 2.5 mL potassium ferricyanide. The
mixture was then incubated at 50 C for 20 min. A volume of
2.5 mL of trichloroacetic acid was added to this mixture, which
was then centrifuged at 3000 r/min for 30 min. Finally, 2.5 mL
of the supernatant solution was collected and mixed with 2.5 mL
of distilled water and 0.5 mL ferric chloride and absorbance was
measured at 700 nm [9].
2.8.3. Nitric oxide radical scavenging activity
The nitric oxide radical scavenging activity of the extract was
determined by mixing 2 mL of 10 mmol/L sodium nitropruside
prepared in 0.025 mol/L of phosphate buffer (pH 7.4) with
0.5 mL of ascorbic acid or aqueous at concentrations of 20–
200 mg/mL [10]. The mixture was incubated at 25 C for
150 min. A volume of 0.5 mL of the incubated solution was
mixed with 0.5 mL of Griess reagent. The mixture was
incubated at room temperature for 30 min. The absorbance of
the mixture was measured at 540 nm against a phosphate
buffer blank.
Table 2
Summary of the effect of the stem bark extracts on the survival of mice.
Treatments Survival days
Aqueous 30 mg/kg 14.80 ± 3.20
Aqueous 100 mg/kg 14.60 ± 2.29
Aqueous 300 mg/kg 20.00 ± 1.30
D/M 30 mg/kg 13.60 ± 5.70
D/M 100 mg/kg 14.80 ± 4.01
D/M 300 mg/kg 16.80 ± 3.50
Control 10.20 ± 2.00
A-L (4 mg/kg) 24.80 ± 5.20
Johnson Nyarko Boampong et al./Asian Pac J Trop Biomed 2015; 5(6): 446–4504482.9. Analysis of data
GraphPad Prism for Windows version 5 (GraphPad Software,
San Diego, CA, USA) was used for all statistical analyses and P
value <0.05 was considered statistically signiﬁcant. All data
were expressed as mean ± SE (duplicate measurement). The
column graph was subjected to One-way ANOVA with Turkey's
post hoc test.
3. Results
3.1. Preliminary phytochemistry of the extracts
The aqueous and D/M extracts both contained triterpenoids and
ﬂavonoids. Aqueous in addition contained glycosides and sapo-
nins. Tannins were also presented in the D/M extract (Table 1).Table 1
Constituents of stem bark extracts of H. barteri.









+: Present; −: Absent.
Figure 1. Daily curative activity of the aqueous, D/M extracts of H. barteri s
Data is presented as means ± SEM. **: P < 0.01; ***: P < 0.001, compared to v
test). AQ: Aqueous.
Figure 2. Histology of liver sections of control.
H. barteri (30–300 mg/kg) and A-L (4 mg/kg) were used for treating animals.3.2. Daily curative activities and safety proﬁle of stem
bark extracts of H. barteri on P. berghei-induced
malaria
The aqueous and D/M extracts produced signiﬁcant
(P < 0.05) curative antiplasmodial effect starting on Day 5–8
(Figure 1) compared to the saline treated control group. The
longest survival times were achieved at the highest doses of both
aqueous and D/M treated groups as 20.00 ± 2.30 and
16.80 ± 3.50 respectively (Table 2). There was no observed
induced toxicity by both extracts in the liver sections (Figure 2).
3.3. Prophylactic effects of stem bark extracts of H.
barteri on P. berghei-induced malaria
The D/M (30–300 mg/kg) extract did not produce signiﬁcant
prophylactic activity against P. berghei (Figure 3). On the othertem bark and A-L (4 mg/kg) on P. berghei-induced malaria.
ehicle-treated group (Two-way ANOVA followed by Bonferroni's post hoc
AQ: Aqueous.
Figure 3. Prophylactic effect of aqueous (30–300 mg/kg), D/M (30–300 mg/kg) extracts of H. barteri on P. berghei-induced malaria.
Data is presented as mean ± SEM. *: P < 0.05; **: P < 0.01, compared to vehicle treated groups (One way ANOVA followed by Tukey's post hoc test). AQ:
Aqueous.
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(P < 0.000 1) prophylactic activity against P. berghei in vivo at
all the three doses tested as seen as a signiﬁcant reduction of the
parasite count compared to the vehicle-treated group (Figure 3).
Similarly, SP showed signiﬁcant prophylactic activity
(P < 0.01).
3.4. Total antioxidant capacity
The aqueous extract produced concentration-dependent
antioxidant activity. The total antioxidant capacity of aqueous
was (42.5 ± 2.1) mg ascorbic acid equivalents/g extract esti-
mated from the standard curve of ascorbic acid
[y (absorbance) = 9.539x − 0.034; r2 = 0.989 9].
3.5. Ferric-reducing antioxidant power
The aqueous extract and n-propyl gallate exerted a
concentration-dependent antioxidant property in the ferric-
reducing power assay. The potency of aqueous extract was 6.7
times less potent than the standard.
3.6. Nitric oxide radical scavenging activity
The aqueous extract was potent in scavenging the unstable
nitric oxide species. The potency of aqueous was 8.1 times less
potent than ascorbic acid.
4. Discussion
Malaria is an inﬂammatory cytokine-driven disease that often
results in mortality due to sequestered parasitized red cells
preventing sufﬁcient oxygen access to where it is needed
together with mitochondria inability to generate enough adeno-
sine triphosphate to maintain normal cellular function [11].
P. berghei parasite is used in predicting treatment outcomes of
any suspected antimalarial agent due to its high sensitivity to
chloroquine, making it the appropriate parasite for this study
[12]. In this study, three doses of the aqueous and D/M stem
bark extracts of H. barteri exerted curative antimalarial
activities against the blood stage of P. berghei. This implies
that the active principles for the observed antimalarial effects
are present in both the aqueous and D/M fractions. It is
proposed that the presence of alkaloids, tannins, triterpenoids,ﬂavonoids, glycosides and saponins in both fractions could be
responsible for the observed curative antiplasmodial activities
of the two extracts but further experiments are needed to
conﬁrm this hypothesis. Some alkaloids that act against
malaria parasites inhibit protein synthesis by intercalating with
DNA of the parasite [13,14]. In addition, saponin, ﬂavonoids
and tannins have been suggested to act as primary antioxidants
or free radical scavengers that can counteract the oxidative
damage induced by the malaria parasite [15]. Numerous studies
have implicated oxidative stress in several pathological
conditions such as stroke, diabetes, Parkinson's disease and so
on. Apart from their detrimental effects, free radicals are also
involved in cellular signaling and as carriers for iron
requirement needed by parasites for survival in a host. Iron is
a crucial nutrient for survival and replication of
microorganisms such as Plasmodium parasites. Thus, the
ability of an antioxidant to chelate/sequester iron needed by
the Plasmodium parasite will adversely affect the survival of
the parasite in a host. Flavonoids in particular have the ability
to chelate iron and they have been suggested that such
compounds with the ability to sequester iron should be
employed in treatment of infections [16]. Both the aqueous and
D/M extracts contained ﬂavonoids, which possibly contributed
to the antiplasmodial effect observed in the mice.
The aqueous extract also exhibited prophylactic antimalarial
activity contrary to D/M extract. Despite the fact that the phar-
macokinetic properties of the extracts have not yet been deter-
mined, it is likely that the D/M extracts is excreted rapidly
resulting in low blood concentration of the extract before para-
site inoculation. It is also possible that the selective presence of
glycosides and terpenoids in the aqueous extract may be
responsible for its prophylactic activity. Glycosides were how-
ever absent in D/M extract. Some glycosides and terpenoids
attack the broadest age range of parasites, from the tiniest rings
that have recently invaded erythrocytes to more mature stages of
parasites such as developing trophozoites and schizonts [17].
Their relatively broad stage-speciﬁcity of action has been re-
ported to extend to the ability to impede development of ga-
metocytes [17]. The aqueous and D/M extracts did not produce
toxicity in liver of the P. berghei-infected mice. The extracts
may be safe for malaria treatment.
The data provide evidence that stem bark extracts of
H. barteri possess antiplasmodial activity which may partly be
mediated by its antioxidant property.
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